Multicenter, Open-Label (Non-Comparative) Study To Evaluate Changes In Flow Mediated Dilatation During And After A 6 Months Treatment Period With Step By Step Increased Doses With Quinapril Therapy In Post-Menopausal Women With Mild Or Moderate Hypertension.
Latest Information Update: 03 Nov 2021
At a glance
- Drugs Quinapril (Primary)
- Indications Hypertension
- Focus Pharmacodynamics
- Sponsors Pfizer
- 30 Aug 2006 Status change
- 13 Nov 2005 New trial record.